Aspira Women’s Health, Inc. to Participate in BTIG’s Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Get Alerts AWH Hot Sheet
Overall Analyst Rating:
NEUTRAL ( Up)
Dividend Yield: 152.4%
EPS Growth %: -366.7%
Join SI Premium – FREE
AUSTIN, Texas, Feb. 12, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced management will participate and present in the 2021 BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place on February 17-19. Details for the event are below:
BTIG MedTech, Digital Health, Life Science and Diagnostic Tools Conference Presentation: | |
Date:Time:Webcast: | Thursday, February 18, 20219:30 am Eastern Timehttps://wsw.com/webcast/btig3/awh/1583008 |
About Aspira Women’s Health Inc.Aspira Women’s Health, Inc. (formerly known as Vermillion Inc., Nasdaq: VRML) is transforming women’s health with the discovery, development, and commercialization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. ASPIRA is particularly focused on closing the ethnic disparity gap in ovarian cancer risk assessment and developing solutions for pelvic diseases such as pelvic mass risk assessment and endometriosis. OVA1® plus includes our FDA-cleared products, OVA1® and OVERA® to detect risk of ovarian malignancy in women with adnexal masses. ASPIRA GenetiXTM testing offers both targeted and comprehensive genetic testing options with a gynecologic focus. With over 10 years of expertise in ovarian cancer risk assessment, ASPIRA is delivering a portfolio of pelvic mass products over a patient’s lifetime with our cutting-edge research. The next generation of products in development are OVASightTM and EndoCheckTM. Visit our website for more information at www.aspirawh.com.
Investor Relations Contact:Ashley R. Robinson LifeSci Advisors, LLC Tel 617-430-7577[email protected]
Source: Aspira Women's Health Inc.Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Eldorado Gold Reports First Quarter 2024 Financial and Operational Results; Steady Start to 2024
- The First of Long Island Corporation Reports Earnings for the First Quarter of 2024
- Phillips Edison & Company Reports First Quarter 2024 Results and Affirms Full Year Earnings Guidance
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
BTIG, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!